A new therapy shuts down the genetic process that causes eye disease
By Kevin KelleherPosted 01.01.2005 at 1:00 pm 0 Comments
In the seven years since scientists discovered RNA interference, or RNAi—a way of hijacking a cell’s defense mechanism to silence
defective genes—the technology has been hailed
as a potential treatment for everything from cancer
to coronary heart disease. Now scientists are putting it to the test in humans.